Surrogacy and donor egg IVF solve different problems. Surrogacy is needed when a woman cannot carry a pregnancy. Donor egg IVF is needed when she cannot produce viable eggs. The two are not interchangeable, and identifying which problem applies determines the entire treatment path.

According to Dr. Hrishikesh Pai, a leading IVF Doctor in India, “Surrogacy and donor egg IVF are sometimes needed together and sometimes independently. The decision depends entirely on whether the problem is the eggs, the uterus, or both. That has to be established before anything else is decided.”

Donor egg IVF uses eggs from a screened third-party donor, fertilised in the lab with the intended father’s sperm, and transferred into the intended mother’s uterus. She carries and delivers the pregnancy herself. The intended mother has no genetic connection to the child. The intended father does.

Who needs it:

Low or absent ovarian reserve: AMH critically low or ovaries no longer producing viable eggs. Donor eggs remove the reserve problem entirely.

Premature ovarian insufficiency: Ovaries stop functioning before 40. Standard IVF cannot work. Donor eggs are the primary route.

Repeated IVF failure due to poor egg quality: Stimulation repeatedly produces eggs that fail to fertilise or develop. Eggs are the limiting factor.

Genetic conditions: Intended mother carries a heritable condition that preimplantation testing cannot resolve. Donor eggs avoid passing it on.

Age-related egg quality decline: Mid to late 40s where egg quality is the primary barrier to IVF success.

Live birth rates with donor eggs sit at 55 to 60% per fresh transfer in published data, higher than standard IVF because donors are younger and thoroughly screened. Full details are available on the egg donation treatment page.

Surrogacy involves a third party carrying the pregnancy. In gestational surrogacy, the form used in modern IVF, the surrogate has no genetic connection to the child. An embryo created from the intended parents’ eggs and sperm, or from donor eggs and/or sperm, is transferred to the surrogate’s uterus. She carries and delivers the pregnancy on behalf of the intended parents.

Who needs it:

Absent uterus: Women born without a uterus or who have had a hysterectomy cannot carry a pregnancy. Surrogacy is the only route to biological parenthood.

Uterine conditions that prevent pregnancy: Severe Asherman syndrome, fibroids that cannot be surgically corrected, or repeated failed embryo transfers where the uterus is identified as the problem.

Medical conditions where pregnancy is contraindicated: Serious cardiac, renal or other systemic conditions where carrying a pregnancy poses life-threatening risk to the mother.

Recurrent pregnancy loss after normal embryo transfers: When good-quality embryos are transferred into a prepared uterus and miscarriage keeps occurring without explainable cause.

For women in Delhi working through which combination applies, a consultation with an experienced IVF Doctor in Delhi establishes which barrier is operative before any third-party arrangement is considered.

Can surrogacy and donor eggs be used together? Yes. When a woman has neither viable eggs nor a functional uterus, donor eggs are fertilised with the intended father’s sperm and transferred to a gestational surrogate. Both third parties are involved.

For women where low ovarian reserve is the primary concern before considering donation, the guide on low ovarian reserve covers whether own eggs are still a viable option.

Dr. Hrishikesh Pai has been a fertility specialist for over 40 years. MD, FRCOG (UK-HON), MSc (USA), FCPS, FICOG. He founded the Bloom IVF Group from the ground up, now past 25,000 cycles across eight centres in Mumbai, Navi Mumbai, Delhi, Gurgaon and Mohali. The labs run Life Whisperer AI for embryo grading because manual assessment alone has limits.

Bloom IVF offers both donor egg IVF and gestational surrogacy programs. Donors are screened for infectious diseases, haemoglobinopathies and genetic conditions. Expanded carrier screening is available. The egg donation success rate at Bloom IVF is 90% after three attempts.

References

 Trends and Outcomes of Gestational Surrogacy in the United States – PMC, National Library of Medicine
Obstetric Complications of Donor Egg Conception Pregnancies – PMC, National Library of Medicine

Yes, but the picture is more nuanced than the number suggests. Low ovarian reserve means fewer eggs are left, not that conception is impossible. Egg quality drives outcomes far more than quantity, and quality is primarily determined by age. A 32-year-old with AMH of 0.6 ng/mL is in a very different position from a 42-year-old with the same result. The diagnosis is a reason to act quickly, not a reason to stop.

According to Dr. Hrishikesh Pai, a leading IVF Doctor in India, “Low ovarian reserve doesn’t mean zero chance of pregnancy. It means time is working against you and acting quickly makes a real difference.”

Reserve tells you how many eggs are left. What it doesn’t tell you is whether those eggs can lead to pregnancy. Several other factors matter more.

Age comes first: Under 35, even very low AMH rarely closes the door entirely. The eggs that remain tend to be better quality, and the numbers from IVF are meaningfully better than the same diagnosis a decade later.

AMH and AFC together, not AMH alone: AFC on ultrasound tells you how many follicles are visible and ready to respond. Combined with AMH, it gives a far more accurate read than either test separately.

Why the reserve is low: Surgical history, endometriosis, genetic causes, prior chemotherapy  each affects the ovaries differently and responds differently to treatment. Two women with the same AMH number can have very different prognoses depending on cause.

Actual response to stimulation: The AMH number predicts response, it doesn’t determine it. Some women with AMH under 0.5 ng/mL still produce multiple usable eggs with the right protocol. The only way to know is to try.

One good embryo is enough: With low reserve, the goal shifts from retrieving many eggs to identifying the best one available. A single good-quality blastocyst is all it takes.

Women with confirmed low reserve should not delay. Early assessment and tailored planning under poor ovarian reserve treatment gives the most options while eggs are still available.

Treatment is not one-size-fits-all. Age, AMH, AFC and prior treatment history all shape what makes sense.

Timed intercourse with ovulation monitoring: A reasonable starting point for younger women with mild low reserve and regular ovulation. Avoids unnecessary intervention before simpler options are tried.

IUI with ovarian stimulation: Women under 40 with low reserve can achieve reasonable pregnancy rates through IUI before moving to IVF. Less invasive, lower cost per cycle.

IVF with modified protocol and growth hormone: High-dose gonadotropins combined with growth hormone is standard for poor responders. Mini-IVF used when conventional stimulation produces no response.

Egg accumulation across cycles: When only one or two eggs come per retrieval, banking embryos across multiple cycles before transfer increases cumulative live birth rates.

PRP intraovarian injection: Platelet-rich plasma injected into the ovary has shown improvements in AMH, AFC and IVF outcomes in published cohort data. Increasingly used when conventional approaches are exhausted.

Donor eggs: When own eggs are no longer viable, donor egg IVF removes ovarian reserve from the equation entirely. Success rates are high.

Uterine cavity health is assessed in parallel before any embryo transfer is planned. The guide on hysteroscopy before IVF explains why cavity assessment matters before the cycle starts.

Dr. Hrishikesh Pai has been a fertility specialist for over 40 years. MD, FRCOG (UK-HON), MSc (USA), FCPS, FICOG. He founded the Bloom IVF Group from the ground up, now past 25,000 cycles across eight centres in Mumbai, Navi Mumbai, Delhi, Gurgaon and Mohali. The labs run Life Whisperer AI for embryo grading because manual assessment alone has limits.

Poor ovarian reserve management at Bloom IVF is protocol-specific. Growth hormone, egg accumulation, PRP and donor egg options are all available and selected based on individual response, not a standard pathway.

References

In Vitro Fertilization Outcome in Women With Diminished Ovarian Reserve – PMC, National Library of Medicine
Ovarian Reserve Parameters and IVF Outcomes in 510 Women With Poor Ovarian Response Treated With Intraovarian Injection of Autologous PRP – PMC, National Library of Medicine

Ultrasound misses 14 to 45% of uterine cavity abnormalities that hysteroscopy detects. Polyps, adhesions, fibroids and septa reduce implantation independently of embryo quality. Hysteroscopy is the only investigation that diagnoses and treats these in the same procedure.

According to Dr. Hrishikesh Pai, a leading IVF Doctor in India, “The uterine cavity is half the equation in IVF. A normal ultrasound does not mean a normal cavity. Finding a problem and treating it costs far less than a failed cycle.”

The procedure gives a direct view inside the uterine cavity, diagnosing and treating in one sitting.

Endometrial polyps: Most common finding in women with prior IVF failure. Alter the local implantation environment. Hysteroscopic removal improves outcomes.

Submucosal fibroids: Distort the implantation surface and impair blood flow. Hysteroscopic resection consistently improves IVF outcomes.

Intrauterine adhesions: Frequently missed by ultrasound. Obstruct the cavity and prevent implantation. Identified and treated at hysteroscopy.

Uterine septum: Associated with implantation failure and recurrent miscarriage. Hysteroscopic resection is performed at diagnosis.

Chronic endometritis: No symptoms, nothing on ultrasound. Diagnosed by hysteroscopy and biopsy. Antibiotic treatment improves IVF outcomes.

Endometrial fluid: Significantly reduces implantation rates. Hysteroscopy identifies the source before the cycle proceeds.

Women with confirmed cavity pathology should have it addressed through hysteroscopic surgery before starting any IVF cycle.

Two or more failed IVF cycles: Strongest indication. Up to 39% of women with normal prior ultrasound have abnormal cavity findings at hysteroscopy.

Abnormal uterine bleeding: Suggests endometrial pathology that needs exclusion before stimulation starts.

Suspected Mullerian anomalies: Septum or other congenital abnormality on imaging. Hysteroscopy confirms and corrects in one procedure.

Prior uterine surgery: Myomectomy, D&C or caesarean section raises adhesion risk. Hysteroscopy checks for cavity involvement.

Thin or irregular endometrium: When lining preparation consistently underperforms, hysteroscopy rules out intrauterine pathology.

Routine before first IVF cycle: debated. Evidence increasingly supports broader use given how often ultrasound misses relevant findings.

For women working through this decision, cavity risk is assessed based on history and imaging before any cycle proceeds. The guide on thyroid and fertility covers one of the most commonly missed systemic contributors to IVF failure.

Dr. Hrishikesh Pai has been a fertility specialist for over 40 years. MD, FRCOG (UK-HON), MSc (USA), FCPS, FICOG. He founded the Bloom IVF Group from the ground up, now past 25,000 cycles across eight centres in Mumbai, Navi Mumbai, Delhi, Gurgaon and Mohali. The labs run Life Whisperer AI for embryo grading because manual assessment alone has limits.

Hysteroscopy at Bloom IVF is performed as a diagnostic and operative procedure in the same sitting where possible. Cavity assessment is built into the pre-IVF workup for women with prior failures or clinical risk factors.

References

Effect of Hysteroscopy Before Starting In-Vitro Fertilization for Women With Recurrent Implantation Failure: A Meta-Analysis and Systematic Review – PMC, National Library of Medicine
Hysteroscopy Findings After Two Previous Failed IVF Cycles: A Case for Routine Hysteroscopy Before IVF? – PMC, National Library of Medicine

Thyroid hormones regulate ovulation, implantation and early pregnancy. When thyroid function is off, even slightly, fertility is affected. Hypothyroidism is the most common thyroid condition in women of reproductive age and frequently goes undetected because the standard lab reference range is wider than what fertility medicine needs. Most IVF clinics now use a TSH cutoff of 2.5 mIU/L, lower than the standard lab range, because even mild elevation reduces IVF success rates.

According to Dr. Hrishikesh Pai, a leading IVF Doctor in India, “Thyroid function is one of the first things we check in any fertility workup. A TSH that looks normal on a standard report can still be too high for an IVF cycle. The fertility threshold is different from the general population threshold.”

The disruption isn’t confined to one part of the cycle. Thyroid hormones touch the reproductive axis at multiple points simultaneously.

Ovulation: When TSH is elevated, prolactin tends to rise with it. That rise disrupts GnRH signalling. The result is irregular cycles, delayed ovulation or no ovulation at all.

Egg quality: Thyroid hormone receptors sit inside granulosa cells and oocytes directly. Low thyroid function interferes with how follicles develop during stimulation and affects the quality of eggs produced.

Endometrial receptivity: Subclinical hypothyroidism has been associated with thinner endometrial lining and a shifted implantation window. The embryo arrives, but the lining isn’t ready.

Early pregnancy loss: In the first trimester, the foetus has no functioning thyroid. It relies entirely on maternal thyroid hormone. Untreated hypothyroidism at this stage significantly raises miscarriage risk.

Thyroid autoimmunity: This is the one that surprises people most. Elevated TPOAb or TgAb antibodies reduce clinical pregnancy rates and increase miscarriage rates in IVF even when TSH is perfectly normal. The immune dysregulation affects implantation independently of hormone levels.

Thyroid is one piece of a larger picture. Understanding why IVF fails across all the contributing factors is where the investigation has to start before any protocol gets adjusted.

The general population TSH reference range runs from 0.4 to 4.5 mIU/L depending on the lab. That range was not designed with IVF in mind. Reproductive endocrinologists work to a different target, below 2.5 mIU/L before a cycle starts, and that target is maintained through early pregnancy.

Subclinical hypothyroidism: TSH sits between 2.5 and 4.5 with normal free T4. Published IVF data consistently shows lower pregnancy rates and higher miscarriage rates in this group compared to women with TSH below 2.5. Levothyroxine brings TSH into the fertility range before stimulation begins.

Overt hypothyroidism: TSH above 4.5 with low free T4. Levothyroxine is not optional here. No IVF cycle should start until TSH is properly controlled.

Hyperthyroidism: Excess thyroid hormone suppresses ovulation and increases miscarriage risk through a different mechanism. IVF gets deferred until antithyroid medication brings function back to a stable level.

Thyroid antibodies with normal TSH: The evidence is still evolving, but low-dose levothyroxine in TPOAb positive women has shown reduced miscarriage rates in published studies. Most reproductive endocrinologists are now treating this group rather than watching and waiting.

Monitoring during IVF: Ovarian stimulation raises oestrogen, which increases thyroxine-binding globulin. That can push TSH up mid-cycle. Women already on levothyroxine may need a dose adjustment during stimulation. TSH gets rechecked in early pregnancy regardless of where it sat before the cycle.

For women working through thyroid-related fertility questions, antibody testing alongside TSH should be part of the standard workup, not an add-on. On the male side, the guide on sperm DNA fragmentation covers one of the most commonly missed factors investigated in parallel.

Dr. Hrishikesh Pai has been a fertility specialist for over 40 years. MD, FRCOG (UK-HON), MSc (USA), FCPS, FICOG. He founded the Bloom IVF Group from the ground up, now past 25,000 cycles across eight centres in Mumbai, Navi Mumbai, Delhi, Gurgaon and Mohali. The labs run Life Whisperer AI for embryo grading because manual assessment alone has limits.

Thyroid assessment at Bloom IVF goes beyond a standard TSH. Antibody screening, free T4 and cycle-specific monitoring are part of the pre-IVF workup. TSH targets are set to fertility standards, not general population reference ranges.

References

Impact of Thyroid Autoimmunity on In Vitro Fertilization Outcomes and Fetal Weight – PMC, National Library of Medicine
The Influence of Pre-IVF Day 2 TSH Levels on Treatment Success and Obstetric Outcomes – PMC, National Library of Medicine

A standard semen analysis measures count, motility and morphology. It tells you nothing about the DNA inside the sperm. Fragmentation refers to breaks or damage in the genetic material a sperm carries. A sperm can look completely normal and still carry enough DNA damage to affect fertilisation, embryo development and pregnancy outcomes. It is one of the most underdiagnosed contributors to male infertility, most relevant when IVF keeps failing despite good embryo grades.

According to Dr. Hrishikesh Pai, a leading IVF Doctor in India, “A normal semen report does not rule out DNA fragmentation. When couples have good embryos and repeated failure, this is one of the first things we investigate on the male side.”

DNA damage builds up through several routes. Some are reversible with the right intervention. Others require a change in treatment strategy altogether.

Oxidative stress: The most common driver. Reactive oxygen species from smoking, alcohol, poor diet, infection and environmental toxins damage sperm DNA directly during production. The testes have limited natural defence against this.

Varicocele: An enlarged scrotal vein raises testicular temperature and drives up oxidative stress. It is one of the most consistently identified causes of elevated fragmentation, and surgical correction brings the index down measurably.

Heat exposure: Sperm DNA is vulnerable to temperature during production. Prolonged sitting, tight underwear, laptop use and hot baths are all contributing factors that most men have not been told about.

Age: Past 40, fragmentation rates rise steadily. Older paternal age is associated with worse IVF and ICSI outcomes independent of what the female workup shows.

Genital tract infections: Prostatitis and epididymitis trigger inflammatory responses that damage sperm DNA. Both frequently go undetected in standard investigations.

Cancer treatment: Chemotherapy and radiation damage sperm DNA directly. Levels can remain elevated for months after treatment ends.

Clinics generally use a DNA fragmentation index above 25 to 30% as the threshold for intervention. Above that, both natural conception rates and IVF outcomes are meaningfully affected. Men with elevated fragmentation should get a full investigation under male infertility treatment before any further cycle is planned.

In natural conception, heavily fragmented sperm rarely fertilise successfully. In ICSI, fertilisation can still happen because the sperm is injected directly. The damage tends to show up later, in how embryos develop and whether they implant.

Effect on IVF outcomes: Lower fertilisation rates, arrested embryo development, higher miscarriage rates, lower live birth rates. These effects appear even when the semen report and embryo grades look fine on paper.

Antioxidant therapy: Vitamins C and E, coenzyme Q10, carnitine. These reduce oxidative stress and bring the fragmentation index down over a 3-month treatment course, which is roughly how long a new sperm cycle takes to complete.

Varicocele repair: For men with a palpable varicocele, microsurgical correction is one of the most evidence-backed interventions for reducing fragmentation and improving IVF outcomes.

Lifestyle changes: Stopping smoking, cutting alcohol, avoiding heat exposure, improving diet. These address the most modifiable causes and cost nothing to start.

Testicular sperm extraction (TESE): When ejaculate fragmentation stays high despite treatment, sperm taken directly from the testis tends to carry less DNA damage. Using testicular sperm in ICSI has shown improved embryo quality and live birth rates in this group.

For couples navigating unexplained IVF failure, fragmentation testing should be part of the full investigation rather than an afterthought. For more on where fragmentation fits into the broader male workup, the guide on semen analysis covers what standard parameters show and what they miss.

Dr. Hrishikesh Pai has been a fertility specialist for over 40 years. MD, FRCOG (UK-HON), MSc (USA), FCPS, FICOG. He founded the Bloom IVF Group from the ground up, now past 25,000 cycles across eight centres in Mumbai, Navi Mumbai, Delhi, Gurgaon and Mohali. The labs run Life Whisperer AI for embryo grading because manual assessment alone has limits.

Male factor investigation at Bloom IVF goes beyond standard semen analysis. When fragmentation is suspected, DNA integrity testing, hormonal profiling and urological assessment are added before the next cycle is designed.

References

Sperm DNA Fragmentation: Causes, Evaluation and Management in Male Infertility – PMC, National Library of Medicine
Sperm DNA Fragmentation: Unraveling Its Imperative Impact on Male Infertility Based on Recent Evidence – PMC, National Library of Medicine

Unexplained infertility is diagnosed when standard fertility tests reveal no obvious reason why a couple cannot conceive. Blocked tubes, ovulation disorders and low sperm count are all ruled out and everything comes back normal. Up to 30% of couples receive this diagnosis, making it one of the most common categories in reproductive medicine.

According to Dr. Hrishikesh Pai, a leading IVF Doctor in India, “Unexplained infertility doesn’t mean nothing is wrong. It means standard testing hasn’t found it yet. The investigation and treatment approach needs to go further than the basic workup.”

The standard workup covers semen analysis, ovarian reserve testing, confirmed ovulation, uterine cavity assessment and tubal patency. When all of it comes back normal, the label unexplained gets applied. Standard testing has real gaps.

Sperm DNA fragmentation: Normal semen parameters don’t rule out DNA damage. High fragmentation affects fertilisation, embryo development and miscarriage risk. Requires a separate test most couples haven’t had.

Subclinical endometriosis: Doesn’t always cause symptoms and doesn’t show on ultrasound. Only confirmed by laparoscopy. Found in a significant proportion of unexplained infertility cases when laparoscopy is performed.

Chronic endometritis: Low-grade uterine lining inflammation with no obvious symptoms. Diagnosed by hysteroscopy and biopsy. Antibiotic treatment has been shown to improve pregnancy outcomes.

Embryo quality and genetic factors: Poor fertilisation, arrested development or repeated failed transfers despite good embryo grades point toward chromosomal issues. PGT can identify abnormal embryos before transfer.

For couples with repeated failed cycles despite normal investigations, early referral for repeated IVF failure workup adds the investigations the standard pathway leaves out.

Treatment follows a stepped approach. No single protocol fits every couple. Age, duration and what’s already been tried drives the decision.

Expectant management: For younger couples who haven’t been trying long. Natural conception rates are meaningful. Avoiding unnecessary treatment early is reasonable medicine.

IUI with ovulation induction: clomiphene or letrozole with timed insemination. Per-cycle success rates around 8 to 15%. Low cost, low risk compared to IVF.

IVF: When IUI hasn’t worked or age makes waiting a poor trade-off. In unexplained infertility it serves two purposes: treatment and investigation. Fertilisation rates, embryo development and implantation failure only become visible inside a cycle.

ICSI: Used selectively when sperm DNA fragmentation is suspected or standard IVF produces poor fertilisation. Not the default but the right call when fertilisation is the barrier.

PGT-A: For recurrent implantation failure or repeated miscarriage. Screens embryos for chromosomal abnormalities before transfer. Filters out embryos that were never viable.

For couples working through this, the guide on uterine fibroids covers when cavity issues need to be addressed before any treatment begins.

Dr. Hrishikesh Pai has been a fertility specialist for over 40 years. MD, FRCOG (UK-HON), MSc (USA), FCPS, FICOG. He founded the Bloom IVF Group, now past 25,000 IVF cycles across eight centres in Mumbai, Navi Mumbai, Delhi, Gurgaon, and Mohali. The labs run Life Whisperer AI for embryo grading because manual assessment alone has limits.

Unexplained infertility at Bloom IVF is not managed with a standard protocol. The investigation goes beyond the basic workup sperm DNA fragmentation, hysteroscopy, and endometritis screening before a treatment plan is decided. The label unexplained is a starting point, not a conclusion.

References

Role of In Vitro Fertilization in Unexplained Infertility Management: A Systematic Review – PMC, National Library of Medicine
A Treatment Algorithm for Couples With Unexplained Infertility Based on Sperm Chromatin Assessment – PMC, National Library of Medicine

Most women with uterine fibroids conceive without any intervention. Present in 20 to 50% of women of reproductive age, the vast majority carry pregnancies without complication. Where fibroids become relevant to fertility is specific: type, size and location determine the risk, not the diagnosis itself. A fibroid on the outer wall is a different clinical problem from one sitting inside the cavity.

According to Dr. Hrishikesh Pai, a leading IVF Doctor in Delhi, “A fibroid diagnosis is not a fertility diagnosis. What matters is where it sits and what it’s doing. Most women with fibroids will never need intervention to conceive or carry a pregnancy.”

The relationship between fibroids and fertility is almost entirely determined by location. Three types, three very different clinical pictures.

Submucosal fibroids (inside the cavity): Highest fertility risk. Distort the implantation surface, impair blood flow and reduce implantation rates. Surgical removal consistently improves outcomes.

Intramural fibroids (within the uterine wall): Impact varies. Small ones rarely cause problems. Above 4 to 5 cm or pressing against the endometrium, implantation becomes harder.

Subserosal fibroids (outer surface): Least concerning. Generally don’t affect fertility or pregnancy outcomes. Typically left alone.

During pregnancy, most fibroids don’t cause complications. Risks like preterm labour or malpresentation are more likely with large or poorly positioned fibroids, but these are elevated risks, not certainties. For women with confirmed cavity-distorting fibroids, laparoscopic surgery or hysteroscopic removal is worth discussing before fertility treatment starts.

Not every fibroid warrants intervention. The decision is case-specific and involves weighing what the fibroid is actively doing against the risks of removing it.

Submucosal fibroids distorting the cavity: are the clearest case for treatment. Hysteroscopic resection is the standard outpatient, no external incisions, and the evidence for improved pregnancy rates after removal is consistent across multiple studies.

Intramural fibroids above 4 to 5 cm near the endometrium: are commonly removed before IVF when other causes of infertility have been ruled out and when the fibroid’s position suggests it’s affecting implantation. The benefit evidence is less definitive here, but the clinical consensus generally supports removal in this group.

Subserosal and pedunculated fibroids: are typically left alone. Removing them carries the standard risks of myomectomy adhesions, wall thinning, recovery time without the fertility benefit.

Fibroids found incidentally during fertility investigations: don’t automatically need removal. The question isn’t whether a fibroid exists but whether it’s in a position to explain the fertility problem or affect pregnancy outcomes. A fibroid discovered alongside low AMH or a male factor result is a different clinical picture from a fibroid discovered in an otherwise normal workup.

For women weighing all of this, a detailed assessment with an experienced IVF Doctor in India maps the fibroid against the full fertility picture before any decision is made. The guide on semen analysis covers how male factor investigation runs in parallel, since fertility is rarely a one-sided picture. 

Dr. Hrishikesh Pai has been a fertility specialist for over 40 years. MD, FRCOG (UK-HON), MSc (USA), FCPS, FICOG. He founded the Bloom IVF Group, now past 25,000 IVF cycles across eight centres in Mumbai, Navi Mumbai, Delhi, Gurgaon, and Mohali. The labs run Life Whisperer AI for embryo grading because manual assessment alone has limits.

Fibroid management at Bloom IVF is decided case by case. Not every fibroid needs removal before IVF. When it does, the surgical approach, the timing relative to the cycle and the post-operative cavity check are planned together not in separate conversations.

References

 Currently Available Treatment Modalities for Uterine Fibroids – PMC, National Library of Medicine
Minimally Invasive Myomectomy: A Systematic Review of Techniques, Challenges, and Fertility Outcomes – PMC, National Library of Medicine

Insulin resistance and chronic inflammation are what actually drive most of what PCOS does to the body. They disrupt ovulation, affect egg quality and make conception harder than it needs to be. The dietary fix isn’t complicated in principle: lower glycaemic foods, fewer refined carbohydrates, less inflammatory fat. Do that consistently and the hormonal environment starts shifting in a direction that supports pregnancy. PCOS isn’t purely a reproductive condition. Once insulin starts behaving, a lot of what follows, irregular cycles, elevated androgens, poor ovulation, tends to settle with it.

According to Dr. Hrishikesh Pai, a leading IVF Doctor in India, “Diet doesn’t replace treatment, but it changes the baseline treatment works from. For many women with PCOS, what they eat is directly changing how their hormones behave.”

There is no single PCOS diet, and anyone presenting one should be questioned. What the research actually supports is a direction: low glycaemic, high fibre, anti-inflammatory. The Mediterranean approach keeps showing up in trials not because it’s fashionable but because it fits that description without making daily eating feel like a protocol.

Whole grains over refined ones: Oats, brown rice, quinoa, whole wheat. These slow insulin rise and reduce androgen production in the ovaries.

Vegetables and legumes, every day Lentils, chickpeas, spinach, broccoli, beans. Fibre slows glucose absorption and supports oestrogen metabolism. PCOS-specific, not generic advice.

Protein at every meal: Eggs, fish, chicken, tofu, paneer. Stabilises blood sugar and reduces insulin swings that worsen PCOS symptoms.

Healthy fats over saturated ones Olive oil, nuts, avocado, fatty fish. Omega-3s from fish, flaxseed and walnuts improve androgen levels and cycle regularity in PCOS trials.

Low-GI fruits Berries, apples, pears, guava. Mango, banana and watermelon are fine occasionally, not as a daily staple.

Inositol-containing foods: Citrus fruits, whole grains, legumes, nuts. Inositol improves insulin signalling and has been studied for ovulation outcomes in PCOS.

The Mediterranean pattern has the most consistent evidence across published PCOS trials. Consistent direction matters more than perfect adherence. Women wanting this built into a fertility plan should raise it as part of PCOS fertility treatment rather than managing food and medicine separately.

Most women with PCOS know sugar is working against them. What tends to catch people off guard is how quickly specific foods produce a hormonal response, and how precisely that response targets ovulation.

Refined carbohydrates and sugar: White rice, white bread, maida, pastries, packaged cereals spike insulin within the hour. In PCOS that triggers androgen release from the ovaries the same day.

Ultra-processed and fast food: Ready meals, packaged snacks, instant noodles combine saturated fat, refined starch and sodium, hitting inflammation and insulin pathways at once.

Sugary drinks: Juice, sweetened chai, energy drinks, cold drinks. Liquid sugar absorbs faster than solid food with no fibre to slow it. A glass of juice does more hormonal damage than eating the actual fruit.

Alcohol: Interferes with oestrogen clearance in the liver and chips away at insulin sensitivity over time. Regular drinking adds hormonal instability to an already dysregulated system.

Understanding how PCOS affects fertility at the ovulation level makes all of this easier to act on. These food changes produce hormonal responses faster than most expect, often within weeks. For women managing PCOS alongside fertility treatment, a proper assessment helps establish whether dietary changes alone are enough or whether medical support is needed too.

Male factor investigations at Bloom IVF go beyond standard semen analysis when the picture isn’t clear. DNA fragmentation, hormonal profiling and urological assessment are brought in when the initial report raises questions rather than answers them.

References

Dietary Modification for Reproductive Health in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis – PMC, National Library of Medicine
Dietary Approaches to Women’s Sexual and Reproductive Health – PMC, National Library of Medicine

A semen analysis evaluates male fertility by testing sperm count, movement (motility), shape (morphology) and fluid volume. To read the results, you compare each metric against WHO reference values the baseline standards for healthy sperm established through population data. Male factor infertility contributes to roughly half of all infertility cases. A semen analysis is where that investigation starts. One abnormal result doesn’t close the door but it tells you where to look next.

According to Dr. Hrishikesh Pai, a leading IVF Doctor in India, “A semen report is not a pass or fail. It is a map. Each parameter tells you something different, and understanding what you’re looking at changes how the couple’s treatment is planned.”

The test covers several parameters, each measuring a different aspect of sperm health. A result outside normal range on one parameter means something different from a result outside range on three simultaneously. That context matters.

These figures come from the WHO 6th Edition manual (2021). Many labs in India still use the older 2010 values worth checking which edition your lab runs before interpreting results.

Three terms that appear in most reports:

Azoospermia: No sperm found in the ejaculate, either due to a production failure or a blockage. Two very different causes, treated very differently.
Oligospermia: Sperm concentration falls below 16 million per mL, reducing the number available to reach and fertilise the egg.
Asthenospermia: Sperm are moving sluggishly or not moving forward, making fertilisation harder even when count is normal.
Teratospermia: The majority of sperm have abnormal shape, affecting their ability to bind to and fertilise the egg.

For couples where parameters are outside normal range, early assessment of male infertility treatment options gives the most planning time.

Getting the report is one thing. Making sense of the numbers without clinical context is where most people struggle. A few things worth knowing before the appointment:

One test is rarely enough: Sperm Production cycles every 72 days. A single result can be thrown off by fever, illness, stress, alcohol or abstinence period. Two tests done 4 to 12 weeks apart give a more reliable picture than one.

Morphology is the most misread number: A result of 4% normal forms looks alarming. It isn’t automatic. The WHO’s 4% threshold is a lower reference limit, not an ideal value. Men with morphology at 3% have fathered children naturally. What morphology tells you is about the proportion of normally shaped sperm, and it rarely acts in isolation.

Motility type matters more than total motility: Progressive motility sperm swimming forward is more clinically relevant than total motility, which includes sperm that are moving but going nowhere useful. A report showing 45% total motility but only 15% progressive motility is more concerning than it looks at first read.

Volume and pH together tell a story: Very low volume with acidic pH can indicate ejaculatory duct obstruction or seminal vesicle dysfunction structural problems rather than sperm production problems. High volume with low concentration is a different picture again.

DNA fragmentation isn’t on a standard report: Routine semen analysis doesn’t test sperm DNA integrity. Worth requesting separately if the basic report looks normal but conception still isn’t happening. On the female side, the guide on PCOS fertility diet covers how diet directly affects ovulation in one of the most common fertility conditions.

Dr. Hrishikesh Pai has been a fertility specialist for over 40 years. MD, FRCOG (UK-HON), MSc (USA), FCPS, FICOG. He founded the Bloom IVF Group, now past 25,000 IVF cycles across eight centres in Mumbai, Navi Mumbai, Delhi, Gurgaon, and Mohali. The labs run Life Whisperer AI for embryo grading because manual assessment alone has limits.

Male factor investigations at Bloom IVF go beyond standard semen analysis when the picture isn’t clear. DNA fragmentation, hormonal profiling and urological assessment are brought in when the initial report raises questions rather than answers them.

References

 A Review of Semen Analysis: Updates From the WHO Sixth Edition Manual and Advances in Male Fertility Assessment – PMC, National Library of Medicine
Semen Evaluation: Methodological Advancements in Sperm Quality-Specific Fertility Assessment – PMC, National Library of Medicine

Sequential embryo transfer is an advanced IVF technique where two separate transfers happen within a single cycle. An early-stage embryo at day 2 or 3 goes in first. A more developed blastocyst follows on day 5 or 6. The first transfer isn’t just an additional attempt; it actively primes the uterine environment, triggering local signals that can make the endometrium more receptive by the time the blastocyst arrives. For patients who’ve had repeated implantation failure, that priming effect is exactly what the protocol is trying to leverage.

According to Dr. Hrishikesh Pai, a leading IVF Doctor in India, “Sequential transfer gives us two biological windows within the same cycle. The first embryo does work the second one benefits from. For patients where implantation has repeatedly failed, that distinction matters.”

The procedure runs across two days within one endometrial preparation cycle. Nothing resets between the two transfers.

Day 2 or 3 A cleavage-stage embryo is transferred first, one or two depending on quality and clinical judgment.

Day 5 or 6: A blastocyst follows. Both embryos are present in the uterus simultaneously from this point.

Why two transfers, not one: The first embryo primes the endometrium by triggering local immune and cytokine changes. The blastocyst arrives into a lining that has already responded. Published systematic reviews show consistently higher clinical pregnancy rates with sequential transfer compared to cleavage-stage transfer alone.

Who it suits: Women with recurrent implantation failure, patients where blastocyst-only transfer has failed, and older patients where blastocyst development is uncertain.

Embryo numbers matter: Sequential transfer needs enough viable embryos to run both days. Limited numbers make the day 5 transfer uncertain. Women exploring this should review the full sequential embryo transfer pathway before committing to a cycle plan.

The clearest indication: A history of repeated IVF failure where implantation is the suspected problem. Three or more failed cycles with good embryo grades and no clear explanation is exactly the profile sequential transfer was designed for.

Not a first-cycle strategy: For women new to IVF, single blastocyst transfer is simpler and has a strong evidence base. Sequential transfer adds coordination, additional embryo use and twin risk that isn’t justified when simpler approaches haven’t been tried.

Twin risk is real: Both embryos are present in the uterus from day 5. Multiple pregnancy is a genuine possibility and gets discussed before the cycle starts. Some clinics use a single cleavage embryo on day 3 specifically to manage this risk while keeping the priming effect.

Sort cavity issues first: submucosal fibroids, adhesions and fluid reduce implantation regardless of transfer protocol. The guide on uterine fibroids covers which types affect implantation and when they need to be addressed before any IVF cycle begins.

Dr. Hrishikesh Pai has been a fertility specialist for over 40 years. MD, FRCOG (UK-HON), MSc (USA), FCPS, FICOG. He founded the Bloom IVF Group, now past 25,000 IVF cycles across eight centres in Mumbai, Navi Mumbai, Delhi, Gurgaon, and Mohali. The labs run Life Whisperer AI for embryo grading because manual assessment alone has limits.

Sequential transfer at Bloom IVF is not a default upgrade. It’s recommended when the history and embryo profile support it. The day 3 and day 5 decisions are made together, not independently, and the twin risk conversation happens before the cycle starts.

References

PMC, National Library of Medicine: Effect of Sequential Embryo Transfer on In Vitro Fertilization and Embryo Transfer Outcomes: A Systematic Review and Meta-Analysis PMC, National Library of Medicine:Sequential Embryo Transfer Efficacy in Enhancing Pregnancy Outcomes: A Systematic Review and Meta-Analysis